Healthcare Data for Achieving a More Personalized Treatment of Chronic Kidney Disease
The current concept of healthcare incites a more personalized treatment of diseases. To this aim, biomarkers are needed to improve decision-making facing chronic kidney disease (CKD) patients. Prognostic markers provided by real-world (observational) evidence are proposed in this Special Issue entit...
Main Authors: | Francisco Herrera-Gómez, F. Javier Álvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/5/488 |
Similar Items
-
Nutrition Prescription to Achieve Positive Outcomes in Chronic Kidney Disease: A Systematic Review
by: Susan Ash, et al.
Published: (2014-01-01) -
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions
by: Maria Antonietta Barbieri, et al.
Published: (2020-05-01) -
Disease characteristics and outcomes in patients with chronic kidney disease and type 2 diabetes: a matched cohort study of spironolactone users and non-users
by: Michael Blankenburg, et al.
Published: (2020-02-01) -
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
by: Stella Bernardi, et al.
Published: (2017-07-01) -
Real-world evidence study for distribution of traditional Chinese medicine syndrome and its elements on chronic bronchitis in China
by: Qing Kong, et al.
Published: (2019-12-01)